Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-26-003538

CVP, TAVR sold 1,019 shares at $85.38 ($87,004)

  • CVP, TAVR acquired 1,019 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lippis Daniel J. · CVP, TAVR

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-11 Exercise or conversion : show line 1 in the form 10b5-1 +1,019 $59.26 $60,383 34,952.91 D
2026-03-11 Sale : show line 2 in the form 10b5-1 −1,019 $85.38 $87,004 33,933.91 D
Open-market sales · 1,019 sh · avg $85.38 · $87,004

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-11 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −1,019 3,057 D
Loading xslF345X05/doc4.xml…